In the current study, we investigated the effects of combined PI3Kα and mTOR inhibition in two of the highest risk category medulloblastoma cells, with DAOY cells representing the SHH, TP53 mutant and D556 cells representing the Group 3 MYC amplified categories35. This evidence concerns the gene SHH and medulloblastoma.